CTRI/2021/11/038069尚未招募3 期
Comparison of 0.1% Nepafenac and 0.3% Nepafenac eye drops in reduction of macular thickness and improvement of visaul acuity in patient with diabetic macular edema - a randomized controlled trial
JIPMER PONDICHERRY0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient age > 18 years
- •2.DME- macular thickness > 250 microns
- •3.BCVA â?? 6/12 or better, 20/40 letters of ETDRS chart.
排除标准
- •1.Any ocular surgical procedure in past 3 months
- •2.Any laser/ intra-vitreal injection procedures in past 3 months.
- •3.Any patient who had undergone cataract surgery in the study eye in past 1 year.
- •4.Vision 6/18 or poor or 20/60 on ETDRS chart.
- •5.Uncontrolled sugar
- •6. Any previous history of allergy to nepafenac.
研究者
相似试验
尚未招募
4 期
STUDY OF EFFECT OF NEPEFENAC ON SWELLING OF CENTRAL RETINA AFTER CATARACT SURGERY.CTRI/2020/09/028097SANKARA EYE HOSPITAL SHIVAMOGGA
招募中
4 期
A study comparing efficacy of two drops in patients undergoing a laser for closed anglesCTRI/2018/10/016227Aravind Eye Hospital
已完成
不适用
To compare efficacy of two drugs in maintaining pupillary dilatation during Phaco emulsification surgery.CTRI/2018/01/011277I160
尚未招募
不适用
pain management post PRKCTRI/2020/07/026874Srikiran eye institute
已完成
不适用
Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal InjectionsPainNCT03406689University Hospital of Patras99